Drug Approval | December 23, 2023
Zydus Lifesciences' API site in Ahmedabad. receives 6 observations from USFDA
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
This PAI-cum-GMP USFDA inspection was conducted from December 14 to December 22, 2023
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
The inspection was a cGMP Inspection and had ended with NIL observations
The cognitively operated system is a mother patent invention, first launched in India
Prime Minister said that it is a huge day for health in Gujarat and congratulated everyone associated with these projects for completing them on time.
The company will address the observations within a stipulated timeline working with the regulators
New Regional Processing Lab will serve Ahmedabad and the state of Gujarat
The transplant procedure was completed in under two hours
Appointment strengthens Medanta’s pediatric super-specialty and respiratory care services in the Delhi-NCR region.
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
Subscribe To Our Newsletter & Stay Updated
